Showing results (521-530 of 11,113) with videos related to

Sort By:
Pageof 1,112
Pharmaceuticals (Basel, Switzerland)|November 28, 2013
Heat shock protein 90 (hsp90) expression and breast cancerFlora Zagouri, Evangelos Bournakis, Konstantinos Koutsoukos, et al.
Pharmaceuticals (Basel, Switzerland)|November 14, 2013
Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challengesAlfredo Erazo-Oliveras, Nandhini Muthukrishnan, Ryan Baker, et al.
Pharmaceuticals (Basel, Switzerland)|November 12, 2016
Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and PerspectivesVanessa Lopes-Rodrigues, Emília Sousa, M Helena Vasconcelos
Pharmaceuticals (Basel, Switzerland)|January 10, 2017
Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library ScreeningChristian Nienberg, Claudia Garmann, Andreas Gratz, et al.
Pharmaceuticals (Basel, Switzerland)|January 10, 2017
CK2-An Emerging Target for Neurological and Psychiatric DisordersJulia Castello, Andre Ragnauth, Eitan Friedman, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2016
Drosophila Protein Kinase CK2: Genetics, Regulatory Complexity and Emerging Roles during DevelopmentMohna Bandyopadhyay, Scott Arbet, Clifton P Bishop, et al.
Pharmaceuticals (Basel, Switzerland)|October 11, 2016
Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic EmergesPeter W Piper, Stefan H Millson
Pharmaceuticals (Basel, Switzerland)|October 11, 2016
Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo ExperimentsVladimir V Zarubaev, Angelica V Garshinina, Nelly A Kalinina, et al.
Pharmaceuticals (Basel, Switzerland)|October 11, 2016
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in GlioblastomaSabrina Höbel, Chantal C M Appeldoorn, Pieter J Gaillard, et al.
Pageof 1,112